Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Short Report as of Oct 31
View:
Post by Mole101 on Nov 06, 2020 2:29pm

Short Report as of Oct 31

All gone ..;)

  • Oct 31, 2020
    Shares Shorted: 17,392 
    Net Change: -450,405
  • Oct 15, 2020
    Shares Shorted: 467,797 
    Net Change: 9,565
  • Sep 30, 2020
    Shares Shorted: 458,232 
    Net Change: -119,185
  • Sep 15, 2020
    Shares Shorted: 577,417 
    Net Change: 90,710
Comment by Actuarial on Nov 06, 2020 2:34pm
The shorts will come back when the SP move up to a certain level. And, the PP participants will dump their .12 shares soon. Who doesn't want an immediate 40% return and hold warrants for free?
Comment by Annayya on Nov 06, 2020 2:40pm
The qualification date is four months after closing of PP so I don't think they can sell anything at a low price anytime soon. A lot can happen in progress in four months especially with aducanumab being approved now, so I am not worried.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse